A case of myelodysplastic syndrome with an intronic point mutation of the p53 tumour suppressor gene at the splice donor site

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 564-566

  Kikukawa, Masayuki ^a   Aoki, Naoto ^b   Mori, Mayumi ^a  

^a Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Abnormal splicing; Chromosome 17 monosomy; Intronic splice donor site mutation; Myelodysplastic syndrome; p53

Indexed keywords

PROTEIN P53;

AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CASE REPORT; CHROMOSOME 17; DNA DETERMINATION; GENE FUNCTION; GENE MUTATION; HUMAN; INTRON; MALE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; CHROMOSOMES, HUMAN, PAIR 17; GENES, P53; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; POINT MUTATION; RNA SPLICING;

EID: 0031811163     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00599.x     Document Type: Article

References (12)

1. Adamson, D.J.A., Dawson, A.A., Bennett, B., King, D.J. & Haites, N.E. (1995) p53 mutation in the myelodysplastic syndromes. British Journal of Haematology, 89, 61-66.
2. Finlay, C.A., Hinds, P.W. & Levine, A.J. (1989) The p53 protooncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
3. Foti, A., Bar-Eli, M., Ahuja, H.G. & Cline, M.J. (1990) A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation. British Journal of Haematology, 76, 143-145.
4. Hollstein, M., Sidransky, D., Vogelstein B. & Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
5. Jonveaux, Ph., Fenaux, P., Quiquandon, I., Pignon, J.M., Lai, J.L., Loucheux-Lefebvre, M.H., Goossens, M., Bauters, F. & Berger, R. (1991) Mutations in the p53 gene in myelodysplastic syndromes. Oncogene, 6, 2243-2247.
6. Kikukawa, M., Aoki, N. & Mori, M. (1996) A case of refractory anaemia with p53 point mutation at codon 249 (AGG to ATG). British Journal of Haematology, 92, 831-833.
7. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
8. Levine, A.J., Chang, A., Dittmer, D., Notterman, D.A., Silver, A., Thorn, K., Welsh, D. & Wu, M. (1994) The p53 tumor suppressor gene. Journal of Laboratory and Clinical Medicine, 123, 817-823.
9. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
10. Metz, T., Harris, A.W. & Adams, J.M. (1995) Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell, 82, 29-36.
11. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Ishikawa, F., Takaku, F., Yazaki, Y. & Hirai, H. (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood, 79, 2378-2383.
12. Takahashi, T., D'Amico, D., Chiba, I., Buchhagen, D.L. & Minna, J.D. (1990) Identitication of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. Journal of Clinical Investigation, 86, 363-369.